Log in to your Inderes Free account to see all free content on this page.
Qlife Holding
1.26 SEK
-5.26 %
Less than 1K followers
QLIFE
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-5.26 %
-41.67 %
-66.04 %
-35.88 %
-37.06 %
-41.68 %
-99.80 %
-99.97 %
-99.95 %
Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.
Read moreMarket cap
19.76M SEK
Turnover
39.4K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Latest research
Latest analysis report
Released: 07.12.2023
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
11.2.
2026
Annual report '25
13.5.
2026
Interim report Q1'26
27.5.
2026
General meeting '26
All
Research
Webcasts
Press releases
ShowingAll content types
BioStock: Qlife remains focused on planned merger with Chinese Hipro
Qlife Holding AB: QLIFE HOLDING AB, Interim Report Q3, July - September 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio